Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $40.26 $52.54 Friday, 10th May 2024 RARE stock ended at $40.90. This is 0.776% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 3.23% from a day low at $40.26 to a day high of $41.56.
90 days $40.26 $54.55
52 weeks $31.52 $54.98

Historical Ultragenyx Pharmaceutical Inc. prices

Date Open High Low Close Volume
Jun 20, 2023 $48.20 $50.73 $48.20 $50.13 753 163
Jun 16, 2023 $49.28 $49.28 $48.05 $48.28 839 915
Jun 15, 2023 $49.83 $49.95 $48.69 $48.86 607 580
Jun 14, 2023 $52.56 $52.79 $49.71 $50.09 629 285
Jun 13, 2023 $51.77 $52.92 $51.31 $52.03 557 601
Jun 12, 2023 $51.79 $52.26 $50.62 $51.40 395 049
Jun 09, 2023 $51.62 $51.89 $51.00 $51.38 396 149
Jun 08, 2023 $51.65 $52.39 $51.31 $51.58 490 309
Jun 07, 2023 $51.91 $52.57 $49.80 $51.82 631 211
Jun 06, 2023 $54.01 $54.98 $50.78 $51.48 1 085 739
Jun 05, 2023 $50.59 $51.93 $50.05 $51.25 554 234
Jun 02, 2023 $51.04 $51.47 $49.90 $50.85 447 795
Jun 01, 2023 $49.35 $50.00 $48.10 $49.61 359 688
May 31, 2023 $48.56 $50.05 $47.82 $49.36 506 410
May 30, 2023 $50.76 $51.29 $48.07 $48.41 601 041
May 26, 2023 $49.71 $50.29 $48.85 $49.83 559 694
May 25, 2023 $50.17 $50.50 $49.55 $49.92 754 494
May 24, 2023 $51.34 $51.34 $49.84 $49.98 386 060
May 23, 2023 $50.54 $52.15 $50.21 $51.42 841 525
May 22, 2023 $50.03 $50.73 $49.77 $50.71 789 140
May 19, 2023 $51.24 $52.11 $49.21 $49.90 1 039 135
May 18, 2023 $49.21 $51.06 $49.10 $50.92 1 156 909
May 17, 2023 $47.25 $49.22 $46.55 $49.15 797 369
May 16, 2023 $47.87 $47.87 $46.26 $46.69 587 484
May 15, 2023 $47.00 $49.37 $46.93 $49.02 716 489
Click to get the best stock tips daily for free!

About Ultragenyx Pharmaceutical Inc.

Ultragenyx Pharmaceutical. Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast growth factor 23 for the treatment of X-linked hypophosphatemia, as well as tumor-induced osteomalacia... RARE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT